The Institute's postdoc award for women in science, funded by generous donors, supports talented Israeli women such as Dr. Michal Leskes. The award meant she could do her postdoc at Cambridge; today, at the Weizmann Institute, her work includes improving the lithium-ion batteries we use for everything from cell phones to electric cars.
January 13, 2016
Prof. Moshe Oren has spent decades studying the p53 gene, which plays a key role in keeping healthy cells from turning cancerous. His basic research has inspired other scientists to build on his findings, potentially leading to p53-based cancer treatments. As head of the Moross Integrated Cancer Center, Prof. Oren's knowledge will be more valuable than ever.
January 05, 2016
The perennially most popular New Year's resolution is to lose weight and be healthy – and yet most people fail. But why? Thanks to the Weizmann Institute, we now have the answer. And it's not your fault; it's your microbiome's. The Personalized Nutrition Project's surprising results show that what you eat does matter – but maybe not in the way you think.
December 21, 2015
After earning his master's at Weizmann's Feinberg Graduate School, Eran Hodis, 29, discovered two of the most common genetic mutations in all of cancer. Now an MD-PhD candidate at Harvard and MIT, he credits Weizmann—and in particular, his mentors Profs. Eran Segal and Joel Sussman—with launching his scientific career.
September 09, 2015
Under quantum theory, particles can be in different places, in different states, doing different things – at the same time. And computers based on these principles might complete, reasonably quickly, calculations that would take today's computers a million years. Weizmann scientists are leading the quest to develop the next generation of computers.
July 23, 2015
The summer before she entered college, Dr. Shari-Lynn Odzer spent a month on the Institute's campus as part of the Bessie F. Lawrence International Summer Science Institute (ISSI). More than three decades later, her daughter Jamie followed in her footsteps.
July 15, 2015
Prof. Yair Reisner is expert at tricking the immune system into accepting trans¬plants it would normally reject. He made a lifesaving breakthrough that lets immunocompromised patients receive bone marrow from a mismatched donor, then expanded the method to leukemia patients – and as if that's not enough, he's now applying it to organ transplants.
June 19, 2015
Prostate cancer is the second leading cause of cancer-related deaths among American men. That's why Prof. Avigdor Scherz, collaborating with other leading cancer researchers, is developing a promising new treatment: vascular-targeted photodynamic therapy, or VTP. Now in clinical trials, VTP uses light and a unique drug to destroy prostate tumors.
May 28, 2015
May is Melanoma/Skin Cancer Detection and Prevention Month: the perfect opportunity to learn more about the disease – and what the Weizmann Institute of Science is doing to help.
May 12, 2015